Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent

Michael J. Bickerdike, Elizabeth Abercrombie

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BEHAVIORAL sensitization to chronic amphetamine develops in parallel with an enhancement of amphetamine-stimulated efflux of acetylcholine (ACh) in striatum. The present study investigated the role of NMDA receptors in the latter phenomenon. Rats were treated with either saline (1.0 ml/kg, i.p.) or amphetamine (4.0 mg/kg, i.p., b.i.d.) for 12 days followed by a withdrawal period of 2-3 weeks. In vivo microdialysis was employed to measure striatal ACh efflux. Amphetamine challenge (4.0 mg/kg, i.p.) evoked a significant increase in striatal ACh efflux in rats withdrawn from chronic amphetamine while having no significant effect on ACh efflux in saline-pretreated rats. Inclusion of the NMDA receptor antagonist (±)-2-amino-5-phoshonopentanoic acid (APV; 100 μM) in the perfusion solution blocked the amphetamine- induced increase in striatal ACh efflux observed in amphetamine-pretreated rats. In saline-pretreated animals, the presence of APV had no apparent effect on the profile of striatal ACh efflux following amphetamine challenge. Thus, the stimulatory effect of amphetamine challenge on striatal ACh efflux that selectively is observed in animals withdrawn from chronic amphetamine is dependent upon NMDA receptor activation.

Original languageEnglish (US)
Pages (from-to)77-80
Number of pages4
JournalNeuroReport
Volume10
Issue number1
DOIs
StatePublished - Jan 18 1999

Fingerprint

Amphetamine
N-Methylaspartate
Acetylcholine
Corpus Striatum
N-Methyl-D-Aspartate Receptors
Microdialysis
Perfusion

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{c987ed53e8d14e4d84b192ab5122502d,
title = "Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent",
abstract = "BEHAVIORAL sensitization to chronic amphetamine develops in parallel with an enhancement of amphetamine-stimulated efflux of acetylcholine (ACh) in striatum. The present study investigated the role of NMDA receptors in the latter phenomenon. Rats were treated with either saline (1.0 ml/kg, i.p.) or amphetamine (4.0 mg/kg, i.p., b.i.d.) for 12 days followed by a withdrawal period of 2-3 weeks. In vivo microdialysis was employed to measure striatal ACh efflux. Amphetamine challenge (4.0 mg/kg, i.p.) evoked a significant increase in striatal ACh efflux in rats withdrawn from chronic amphetamine while having no significant effect on ACh efflux in saline-pretreated rats. Inclusion of the NMDA receptor antagonist (±)-2-amino-5-phoshonopentanoic acid (APV; 100 μM) in the perfusion solution blocked the amphetamine- induced increase in striatal ACh efflux observed in amphetamine-pretreated rats. In saline-pretreated animals, the presence of APV had no apparent effect on the profile of striatal ACh efflux following amphetamine challenge. Thus, the stimulatory effect of amphetamine challenge on striatal ACh efflux that selectively is observed in animals withdrawn from chronic amphetamine is dependent upon NMDA receptor activation.",
author = "Bickerdike, {Michael J.} and Elizabeth Abercrombie",
year = "1999",
month = "1",
day = "18",
doi = "10.1097/00001756-199901180-00015",
language = "English (US)",
volume = "10",
pages = "77--80",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent. / Bickerdike, Michael J.; Abercrombie, Elizabeth.

In: NeuroReport, Vol. 10, No. 1, 18.01.1999, p. 77-80.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhanced acetylcholine release in striatum after chronic amphetamine is NMDA-dependent

AU - Bickerdike, Michael J.

AU - Abercrombie, Elizabeth

PY - 1999/1/18

Y1 - 1999/1/18

N2 - BEHAVIORAL sensitization to chronic amphetamine develops in parallel with an enhancement of amphetamine-stimulated efflux of acetylcholine (ACh) in striatum. The present study investigated the role of NMDA receptors in the latter phenomenon. Rats were treated with either saline (1.0 ml/kg, i.p.) or amphetamine (4.0 mg/kg, i.p., b.i.d.) for 12 days followed by a withdrawal period of 2-3 weeks. In vivo microdialysis was employed to measure striatal ACh efflux. Amphetamine challenge (4.0 mg/kg, i.p.) evoked a significant increase in striatal ACh efflux in rats withdrawn from chronic amphetamine while having no significant effect on ACh efflux in saline-pretreated rats. Inclusion of the NMDA receptor antagonist (±)-2-amino-5-phoshonopentanoic acid (APV; 100 μM) in the perfusion solution blocked the amphetamine- induced increase in striatal ACh efflux observed in amphetamine-pretreated rats. In saline-pretreated animals, the presence of APV had no apparent effect on the profile of striatal ACh efflux following amphetamine challenge. Thus, the stimulatory effect of amphetamine challenge on striatal ACh efflux that selectively is observed in animals withdrawn from chronic amphetamine is dependent upon NMDA receptor activation.

AB - BEHAVIORAL sensitization to chronic amphetamine develops in parallel with an enhancement of amphetamine-stimulated efflux of acetylcholine (ACh) in striatum. The present study investigated the role of NMDA receptors in the latter phenomenon. Rats were treated with either saline (1.0 ml/kg, i.p.) or amphetamine (4.0 mg/kg, i.p., b.i.d.) for 12 days followed by a withdrawal period of 2-3 weeks. In vivo microdialysis was employed to measure striatal ACh efflux. Amphetamine challenge (4.0 mg/kg, i.p.) evoked a significant increase in striatal ACh efflux in rats withdrawn from chronic amphetamine while having no significant effect on ACh efflux in saline-pretreated rats. Inclusion of the NMDA receptor antagonist (±)-2-amino-5-phoshonopentanoic acid (APV; 100 μM) in the perfusion solution blocked the amphetamine- induced increase in striatal ACh efflux observed in amphetamine-pretreated rats. In saline-pretreated animals, the presence of APV had no apparent effect on the profile of striatal ACh efflux following amphetamine challenge. Thus, the stimulatory effect of amphetamine challenge on striatal ACh efflux that selectively is observed in animals withdrawn from chronic amphetamine is dependent upon NMDA receptor activation.

UR - http://www.scopus.com/inward/record.url?scp=0033580038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033580038&partnerID=8YFLogxK

U2 - 10.1097/00001756-199901180-00015

DO - 10.1097/00001756-199901180-00015

M3 - Article

C2 - 10094137

AN - SCOPUS:0033580038

VL - 10

SP - 77

EP - 80

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 1

ER -